Partner with Industry to Achieve NIAID’s Mission

Slides:



Advertisements
Similar presentations
Office of Infectious Diseases Computational Challenges for Infectious Diseases Michael Shaw, PhD OID/Office of the Director.
Advertisements

Up date on malaria vaccine
Commercializing Discoveries: Disclosing your Intellectual Property By Ryan N. Fiorini, Ph.D., MBA, MHA Licensing and Commercialization Manager MUSC Foundation.
ARS Midwest Area Technology Transfer Technology Transfer and the Interfaces with the Research Unit, MWA Technology Transfer Office, and Headquarters Office.
The Catholic University of America Office of Technology Transfer Office of Technology Transfer Commercialization of CUA-Developed Technologies February.
Technology Transfer: The NIH Experience Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship Office of Technology.
What we ask in a ROI What it is? Is it related to another invention? Who contributed to making the invention? Who paid for the research? When invention.
Commercialization of the Phase Change Incubator Amy Smith Sarah Bird 12 September 2006.
Characterization of delivery systems for nanomedicine Dr. John A. Dagata.
Partnerships & Alliances Molecular Diagnostics Prof. K. K. Jain MD, FRACS, FFPM CEO, Jain PharmaBiotech Blaesiring 7, 4057 Basel, Switzerland Colloquim.
Ronald J. Huss Associate Vice President for Research and Technology Transfer Director, Office of Technology Management phone:
Intellectual Property: Kenneth Kirkland, Ph.D. Executive Director, Iowa State University Research Foundation (ISURF) Director, Office of Intellectual Property.
Harry Danforth or Sherry A. Cohen Bldg. 003, Rm. 208, BARC-W FAX
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
MRSA in Corrections Danae Bixler, MD, MPH
WIPO Dispute Resolution in International Science & Technology April 25, 2005 Ann M. Hammersla Senior Counsel, Intellectual Property Massachusetts Institute.
Contracts: Negotiations and Key Elements Belinda Vandersluis Operations Director, NCIC CTG.
Technology Transfer at Brookhaven SPAFOA MEMBERS’ MEETING May 21, 2015.
Partnering with the National Institute of Allergy and Infectious Diseases Michael R. Mowatt, Ph.D. Director, Technology Transfer and Intellectual Property.
Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.
SARS Research Resources at NIAID Linda C. Lambert, Ph.D. Program Officer Influenza, SARS, and Related Viral Respiratory Diseases NIAID/NIH/DHHS.
HISTORY The term "proteomics" was first coined in 1997 to make an analogy with genomics, the study of the genes.genomicsgenes Proteome = protein + genome.
Dr. Marie Talnack, Director, TechnologyTransfer Office and Industry Clinic.
NIH Technology Transfer and Ethics Pat Lake, Deputy Director Extramural Technology Transfer NIDDK, NIH FLC – Mid Atlantic Regional Meeting, Rocky Gap,
Luciferase Based Plasmid Reporter System for the Detection and Quantification of Human Respiratory Syncytial Virus Group 14: Oral Report 4, 3/13/08 Melanie.
Introduction to the Offices of Biotechnology & Business Development John L. Harb Director, Office of Biotechnology __________________________________ October.
03/10/2008 Terese Rakow, PhD. Postdoctoral Career Development Course March 10, 2008.
U n i t e d S t a t e s D e p a r t m e n t o f A g r i c u l t u r e A g r i c u l t u r a l R e s e a r c h S e r v i c e Strategic Planning in USDA’s.
Intellectual Property Dr Laura Rush Business Development Manager Research Enterprise Services copyright©NewcastleUniversity 2015.
Evices Software Research Tools Therapeutics Diagnostics Medical Devices Software Research Tools Therapeutics Diagnostics Medic s Startup Technology Transfer.
Thomas Moreland Agricultural Research Service Office of Technology Transfer.
Update on the Development of a Group A Streptococcal Vaccine Fran A. Rubin, Ph.D. Program Officer for Group A Streptococci Respiratory Diseases Branch.
Commercializing USDA Innovations Via Public-Private Partnerships June Blalock Coordinator, Technology Licensing Program USDA, Agricultural Research Service.
First experience of TTO at Russian universities Vladimir Zinov – BRHE Program Expert.
Research Administration Forum May 2005 Tom Hagerty Office of Technology Management.
Review of Research-Related Agreements Between Academic Institutions and Other Entities. Manoja Ratnayake Lecamwasam, PhD Intellectual Property and Innovation.
Non-Influenza Respiratory Virus Vaccines Larry J. Anderson DVD, NCIRD, CDC Atlanta, GA, USA 41 st National Immunization Conference Kansas City, Missouri.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Molecular Diagnostics Market to grow at 8.1% CAGR from 2016 to 2023
Technology Transfer Office
CLINICAL TRIALS.
Infections and Environmental Interactions: Who is Responsible?
Universities and the Commercial World
8th European Immunology Conference
Protecting and exploiting research results at Newcastle University Geraint Lewis – Business Development Manager, Research and Enterprise Services
OTT, Beltsville Area Harry Danforth or Sherry A. Cohen Bldg. 003, Rm. 208, BARC-W FAX
Technology Commercialization & Industry Partnering
Protecting and exploiting research results at Newcastle University Lynda Speed Business Development Manager Research and Enterprise Services
Conflict of Interest (COI) Forms
US Army Medical Research and Materiel Command
How to Protect Yourself from the Flu
Luciferase Based Plasmid Reporter System for the Detection and Quantification of Human Respiratory Syncytial Virus Group 14: Oral Report 3, 2/12/2008 Melanie.
Transfer of Materials, Confidential Information, and Data
The State of Pneumococcal Disease Prevention
Technology Commercialization, UI, and You
Paul Stoffels, MD Vice Chairman, Chief Scientific Officer, Johnson & Johnson.
Protecting and exploiting research results at Newcastle University Dr Catrina Mullan Business Development Manager Research and Enterprise Services 0191.
Human metapneumovirus infection among children in Taiwan: a comparison of clinical manifestations with other virus-associated respiratory tract infections 
Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay  P. Jokela,
Human Gene Therapy Institutional Review Procedures
Development and Laboratory Evaluation of a Real-Time PCR Assay for Detecting Viruses and Bacteria of Relevance for Community-Acquired Pneumonia  Alicia.
2019 Hagerstown Technology Showcase March 21, 2019
TECHNOLOGY TRANSFER • • • The NIH Experience
Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons.
U.S. Army Technology Transfer Mechanisms
US Army Medical Research and Materiel Command
US Army Medical Research and Materiel Command
US Army Medical Research and Materiel Command
Viral detection and viral evasion.
Evidence-based management of bronchiolitis.
Approach: The Cuban Regulatory Strategy
Presentation transcript:

Partner with Industry to Achieve NIAID’s Mission Haiqing Li, M.D., Ph.D. Senior Technology Transfer and Patent Specialist Technology Transfer and Intellectual Property Office (TTIPO) lihai@mail.nih.gov March 21, 2019

Partner with NIAID through TTIPO Exchange Material & Information Material Transfer Agreement (MTA) Confidential Disclosure Agreement (CDA) Non-Clinical Evaluation Agreement (NCEA) and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

NIAID Research Resource https://www.niaid.nih.gov/research/resources Filter Search Results by: Disease or Condition Discipline or Approach Research Stage Resource Type NIAID Division For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Partner with NIAID through TTIPO Collaborative Research Research collaboration agreement (RCA) Clinical trial agreement (CTA) Collaborative research and development agreement (CRADA) and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

CRADA Subject Invention Cytonix Corporation Real time PCR technology used for sensitive, specific detection and quantification of nucleic acid targets For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Partner with NIAID or CDC through TTIPO License Research material, patented technology, software Internal use, evaluation, commercialization and others For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Vaccines SmithKline Beecham Vaccine against Hepatitis A Serum Institute of India Heat stable rotavirus vaccine, protecting against five most common rotavirus serotypes For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Therapeutics & Diagnostics MedImmune Immunoprophylaxis to reduce respiratory syncytial virus (RSV) related hospitalizations in high-risk infants and children PATH Biplex test for combined surveillance of Onchocerciasis (river blindness) and Lymphatic filariasis (elephantiasis) For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Veterinary Products Merial Limited Vaccine for dogs against distemper, parvovirus, hepatitis, respiratory disease and parainfluenza virus VCA Antech Diagnostic test for Lyme disease, heartworm, ehrlichiosis, and anaplasmosis in dogs For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

From CDC Becton, Dickinson, and Company (BD) Protecting healthcare workers by detecting contamination from hazardous antineoplastic drugs BD HD Check System AP&G Co., Inc. A low cost mosquito trap that requires neither power nor pesticide Catchmaster Mosquito Trap For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Licensing Opportunities A transferrable Norwalk virus epitope and detector monoclonal antibody Potential Application: Diagnostics and vaccine for Norovirus E-171-2013 Methods to regulate biofilm development Potential Application: Prevent infection on indwelling or implantable medical devices E-449-2013 Small molecule imaging of fungi by positron emission tomography scanning Potential Application: Diagnostics of Aspergillosis and other filamentous fungal infections For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Licensing Opportunities A new class of immunomodulatory drugs for multiple sclerosis Potential Application: Therapeutics for multiple sclerosis E-260-2014 (hMPV) and E-215-2016 (hPIV) Fusion (F) proteins stabilized in prefusion conformation Potential Application: Vaccines for Human Metapneumovirus (hMPV) or Human Parainfluenza Virus (hPIV) E-234-2016 Coronavirus (CoV) spike (S) proteins stabilized in prefusion conformation Potential Application: Subunit vaccine platform for CoV including MERS and SARS For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Licensing Opportunities Real-time PCR assay for detection of carbapenem antibiotic resistance genes of the IMP-type Potential Application: Detection of IMP genes in healthcare settings, antibiotic resistance surveillance E-009-2018 Encapsulated streptococcus compositions and methods Potential Application: Pneumococcal vaccine, probiotic, and diagnostic assay development For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644

Interested in NIAID and CDC Inventions? NIH OTT Licensing: https://www.ott.nih.gov/opportunities Federal Register Notices: https://www.federalregister.gov Biopharma Dealmakers: https://biopharmadealmakers.nature.com/users/15957-niaid-technology-transfer-and-intellectual-property-office For Collaborations or Licensing, Contact the NIAID Technology Transfer and Intellectual Property Office (TTIPO), serving NIAID and CDC: https://www.niaid.nih.gov/about/technology-transfer-intellectual-property Tel: 301-496-2644